Dosing and Safety Profile of Aficamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Caroline J CoatsAhmad MasriMichael E NassifRoberto Barriales VillaMichael AradNuno CardimLubna ChoudhuryBrian Lee ClaggettHans-Dirk DüngenPablo García-PavíaAlbert A HagègeJames L JanuzziMatthew Meng Yang LeeGregory D LewisChang Sheng MaMartin S MaronZi Michael MiaoMichelle MichelsIacopo OlivottoArtur OreziakAnjali Tiku OwensJohn A SpertusScott D SolomonJacob Tfelt HansenMarion van SinttruijeJosef VeselkaHugh C WatkinsDaniel L JacobyPolina GermanStephen B HeitnerStuart KupferJustin D LutzFady I MalikLisa MengAmy WohltmanTheodore P Abrahamnull nullPublished in: Journal of the American Heart Association (2024)
URL: https://www.clinicaltrials.gov; Unique Identifier: NCT05186818.